Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 32Active not recruiting 17Not yet recruiting 5Terminated 3Completed 2Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 24Biopsy 16Magnetic Resonance Spectroscopy 15Cyclophosphamide 5Bevacizumab 4Vincristine 3Taxes 3Prednisone 3Nivolumab 3Doxorubicin 3Cetuximab 3Azacitidine 3venetoclax 2trastuzumab deruxtecan 2prednylidene 2olaparib 2iadademstat 2deltacortene 2decitabine and cedazuridine drug combination 2X-Rays 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Practice Guidelines as Topic 2Paclitaxel 2Ipilimumab 2Immunoglobulin G 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × 130-nm albumin-bound paclitaxel × 30 days × Clear all
NCT05685602 2026-05-18

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
43 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡